Acteoside as a rising star for clinical treatment: Current fundamental research and future outlooks
Journal of Integrative Medicine · 2026
DOI: 10.1016/j.joim.2025.08.007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Integrative Medicine, 2026. Verfasst von Fu-Kun Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Beijing University of Chinese Medicine, Beijing 100029, China. Hauptthemen laut MEDLINE: Glucosides, Phenols. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 109 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Natural compounds are increasingly recognized for their therapeutic potential in disease treatment, and they make a significant contribution to modern pharmaceutical research. Among these compounds, acteoside (ACT), also known as verbascoside and kusaginin, is a phenylethanoid glycoside derived from sources like Rehmannia glutinosa Libosch. and Cistanche deserticola Ma. This natural compound exhibits a range of therapeutic properties, including neuroprotective, anti-inflammatory, anti-bacterial, and anti-tumor effects, thereby underscoring its potential value in addressing various clinical conditions. However, the unstable physicochemical properties and low bioavailability of ACT have greatly limited its clinical application. This review summarizes the latest advancements in pharmaceutical plant resources, conducts bibliometric analysis and explores the pharmacokinetics, pharmacological effects and molecular mechanisms of ACT, providing a deeper understanding of its medicinal value and current research trends. Furthermore, we utilize network pharmacology strategies and molecular docking techniques to identify additional potential therapeutic targets for ACT. We posit that ACT holds considerable promise as a treatment for atherosclerosis, diabetes with complications, hepatic and respiratory diseases as well as common malignant tumors. This review enhances our understanding of the mechanisms by which ACT treats various diseases and establishes a theoretical foundation for further drug development and research on medicinal plants. Please cite this article as: Zhang FK, Jia KX, Wang H, Liu RP, Xue XY, Huo ZX, Li XJY. Acteoside as a rising star for clinical treatment: Current fundamental research and future outlooks. J Integr Med. 2026; 24(1):7-23.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Beijing University of Chinese Medicine, Beijing 100029, China.
- School of Life Sciences, Beijing University of Chinese Medicine, Beijing 100029, China; Department of Neurology, Ningbo Municipal Hospital of Traditional Chinese Medicine, Ningbo 315012, Zhejiang Province, China.
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China.
- School of Life Sciences, Beijing University of Chinese Medicine, Beijing 100029, China. Electronic address: xiaojiaoyang.li@bucm.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, F. K., Jia, K. X., Wang, H., Liu, R. P., Xue, X. Y., Huo, Z. X., & Li, X. J. (2026). Acteoside as a rising star for clinical treatment: Current fundamental research and future outlooks. Journal of Integrative Medicine. https://doi.org/10.1016/j.joim.2025.08.007
Vancouver
Zhang FK, Jia KX, Wang H, Liu RP, Xue XY, Huo ZX, et al. Acteoside as a rising star for clinical treatment: Current fundamental research and future outlooks. Journal of Integrative Medicine. 2026. doi:10.1016/j.joim.2025.08.007
BibTeX
@article{Zhang2026,
author = {Zhang, Fu-Kun and Jia, Ke-Xin and Wang, Hong and Liu, Run-Ping and Xue, Xiao-Yong and Huo, Zi-Xuan and Li, Xiao-Jiao-Yang},
title = {Acteoside as a rising star for clinical treatment: Current fundamental research and future outlooks},
journal = {Journal of Integrative Medicine},
year = {2026},
doi = {10.1016/j.joim.2025.08.007}
}
EUVIMED